Literature DB >> 12955635

Short-course treatment of community-acquired pneumonia.

Lionel A Mandell, Thomas M File.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12955635     DOI： 10.1086/377567

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.

Authors:  P Prokocimer; P Bien; J Surber; P Mehra; C DeAnda; J B Bulitta; G R Corey
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 2.  Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients.

Authors:  Jesús López-Alcalde; Ricardo Rodriguez-Barrientos; Jesús Redondo-Sánchez; Javier Muñoz-Gutiérrez; José María Molero García; Carmen Rodríguez-Fernández; Julio Heras-Mosteiro; Jaime Marin-Cañada; Jose Casanova-Colominas; Amaya Azcoaga-Lorenzo; Virginia Hernandez Santiago; Manuel Gómez-García
Journal:  Cochrane Database Syst Rev       Date:  2018-09-06

Review 3.  Pneumonia in hospitalized children.

Authors:  Thomas J Sandora; Marvin B Harper
Journal:  Pediatr Clin North Am       Date:  2005-08       Impact factor: 3.278

4.  Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization.

Authors:  Katsunaka Mikami; Masaru Suzuki; Hiroshi Kitagawa; Masaki Kawakami; Nobuaki Hirota; Hiromichi Yamaguchi; Osamu Narumoto; Yoshiko Kichikawa; Makoto Kawai; Hiroyuki Tashimo; Hidenori Arai; Tadashi Horiuchi; Yoshio Sakamoto
Journal:  Lung       Date:  2007-08-21       Impact factor: 3.777
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.